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Trends of multidrug-resistant
tuberculosis clustering in Portugal
To the Editor:
Multidrug-resistant (MDR) tuberculosis (TB) represent a major threat for global TB control. In 2017, the
World Health Organization estimated 460000 cases of MDR-TB, of which 8.5% were also extensively
drug-resistant (XDR) cases [1]. In Portugal, over the last decade, the decreasing tendency of TB cases is
about 7% per year, and the proportion of MDR-TB cases remains steadily around 1% of the total TB
cases. In 2017, the preliminary report of the Portuguese national TB programme reported 1607 new cases
of pulmonary TB, with 12 MDR-TB cases [2].
Since 2014, there have been specific centres for the diagnosis, consultancy, monitoring and treatment of
the MDR/XDR-TB cases. Besides providing a clinical approach, these centres also aim to monitor these
resistant cases, linking the epidemiological survey performed within the community by public health
authorities [3] and systematic molecular genotyping performed by the National Reference Laboratory
(NRL). Since the Portuguese NRL receives all the strains isolated from all the MDR-TB patients from
Portugal (mandatory since 2007) [4], this approach could allow a very good correlation between the
genetic and epidemiological information in order to detect both the resistance profiles, as there are
possible relationships between strains due to the occurrence of ongoing transmission [5, 6].
In this study, we intended to analyse the MDR-TB clustering rate in Portugal.
From a total of 78 MDR/XDR-TB strains identified and notified in the country during 2014–2017, 71
(91.0%) were available for molecular analysis. From these 78 strains, seven were not available for further
analysis due to contamination of the culture or MDR diagnosis based only on molecular biology
methodologies (GeneXpert or other line-probe assays). The drug susceptibility profiles are described in
table 1.
For each strain, 24-loci MIRU-VNTR (mycobacterial interspersed repetitive units – variable number of
tandem repeats) genotyping was performed by standardised protocols using a MIRU-VNTR typing kit,
according to the manufacturer’s instructions (GenoScreen, Lille, France). Dendrograms were constructed
using the online free software MIRU-VNTRplus (https://miru-vntrplus.org/MIRU/miruinfo.faces).
A molecular cluster was defined whenever different strains shared the exact MIRU-VNTR profile. All
clusters identified were further analysed with the available epidemiological data.
The majority of the MDR-TB cases were male (75.6%) with a median age of 44.3 years (minimum 15 and
maximum 75 years). Most of these cases were notified in the Lisbon and Tagus Valley (LTV) region
(64.0%) and the North region (23.1%). XDR-TB cases were identified in 15 cases (19.2%), of which 86.7%
were from the LTV region (table 1).
Using MIRU-VNTR, seven different clusters were identified (table 1), ranging from two to 14 strains.
Overall, the proportion of MDR-TB cases attributable to recent transmission in the study period
(2014–2017), on the basis of genetic data, was 63.4% (45 out of 71).
From the analysis of the molecular data, we observed a decreasing tendency of the cases that can be
potentially related to recent transmission. In fact, in 2014, we found six clusters ranging from two to four
strains, corresponding to a clustering rate of 72.7%. The major cluster was from strains isolated in the
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TABLE 1 Microbiological and demographic characteristics of the patients enrolled in the study
Lab no. Diagnosis
year
Exclusion
reason
Sex Age
years
Region of
isolation
MDR/
XDR-TB
STR INH RMP EMB PZA AMI CAP ETI MOX OFL LIN KAN CIC PAS Cluster
no.
S199228 2014 M 42 LTV XDR R R R R R R R R R R S S S S
2014 No culture
isolation
M 43 LTV XDR R R R R R R R R R R S S S S
2014 Only LPA M 47 LTV MDR NA R R NA NA NA NA NA NA NA NA NA NA NA
TB25429 2014 M 41 LTV MDR R R R R R S S R S S S S S S 6
P1595 2014 M 37 LTV MDR R R R S R S S R S S S S S S 1
P1279 2014 F 31 LTV MDR R R R R R S S R S S S R S S
S207797 2014 M 53 LTV MDR R R R S R S S R S S S S S S 2
P1428 2014 M 48 LTV MDR R R R S R S S R S S S S S S 1
P1378 2014 M 50 LTV XDR R R R R R S S R R R S R S S 3
P163 2014 M 53 LTV XDR R R R R R R S R R R S R S S 3
TB24818 2014 F 32 LTV MDR R R R R S S S S S S S S S S 7
P291 2014 M 28 LTV MDR R R R R S S S S S S S S S S
TB25274 2014 M 37 LTV XDR R R R R R S S R S R S R R S
S211891 2014 M 36 LTV MDR R R R R S S S R S S S S S S 7
P1599 2014 M 43 LTV MDR R R R R S S S S S S S S S S 6
P187 2014 M 58 LTV MDR R R R R R S S R S S S S S S 2
P88 2014 M 63 North MDR R R R S S S S S S S S S S S 4
P423 2014 F 75 North MDR R R R S S S S S S S S S S S 4
P292 2014 F 41 North MDR R R R S S S S S S S S S S S 4
P1536 2014 M 23 North MDR R R R S S S S S S S S S S S 4
P729 2014 M 47 North MDR R R R S S S S S S S S S S S
P356 2014 M 42 North MDR S R R S S S S S S S S S S S
P92 2014 M 59 Centre MDR R R R S S S S R S S S S S S 2
P340 2014 M 48 Centre XDR R R R R S R S R S R S R S S 3
2015 Only LPA M 31 LTV MDR NA R R NA NA NA NA NA NA NA NA NA NA NA
P2624 2015 M 28 LTV MDR R R R R S S S R S S S S S S 7
P1928 2015 M 61 LTV MDR R R R R R S S R S S S S S S 1
P1229 2015 M 39 LTV XDR R R R R R R R R R R S R S S 1
P1876 2015 M 55 LTV XDR R R R R R R S R R R S R S S 3
P1926 2015 M 52 LTV XDR R R R R R R R R R R S R S S 1
P2829 2015 M 44 LTV MDR S R R S S S S R S S S S S S 1
P2184 2015 M 75 LTV MDR R R R R R R R R S S S R S S 1
P1994 2015 M 41 LTV MDR R R R S R S S R S S S S S S 2
P2058 2015 M 57 LTV MDR R R R S R S S R S S S S S S
TB24737 2015 M 44 LTV XDR R R R R R R R S R R S R S R
P1585 2015 F 42 LTV MDR R R R R S S S R S S S S S S 3
P2354 2015 F 27 LTV MDR R R R R R R R S S S S R S S
P2471 2015 M 34 LTV MDR R R R R S S S R S S S S S S 3
2015 Only LPA F 32 LTV MDR NA R R NA NA NA NA NA NA NA NA NA NA NA
P884 2015 M 61 LTV MDR R R R S R S S R S S S S S S 2
P2579 2015 M 35 LTV MDR R R R R R S S R S S S S S S
P2452 2015 M 57 North MDR R R R S S S S R S S S S S S 3
P982 2015 M 37 North MDR R R R R R S S S S S S S S S
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TABLE 1 Continued
Lab no. Diagnosis
year
Exclusion
reason
Sex Age
years
Region of
isolation
MDR/
XDR-TB
STR INH RMP EMB PZA AMI CAP ETI MOX OFL LIN KAN CIC PAS Cluster
no.
P1880 2015 M 58 North MDR R R R S S S S S S S S R S S
P2353 2015 M 21 Island of
Madeira
MDR S R R R S S S R S S S S S S 5
P27 2015 M 44 Algarve MDR S R R S S S S R S S S S S S
2015 Only LPA M 39 Alentejo MDR NA R R NA NA NA NA NA NA NA NA NA NA NA
S308144 2016 M 41 LTV XDR R R R R R R S R R R S R S S 3
S309968 2016 F 41 North MDR R R R S S S S S S S S S S S 4
S310368 2016 M 42 North XDR R R R R R R S R R R S R S S 3
S312205 2016 F 63 LTV MDR S R R S R R R R S S S R S S 1
S314371 2016 M 15 LTV MDR R R R R S S S R S S S S S S 6
S324134 2016 M 61 Centre MDR R R R R R S S S S S S R S S
2016 No culture
isolation
F 45 LTV MDR R R R R R NA NA NA NA NA NA NA NA NA
S326551 2016 M 40 LTV MDR R R R R R S S S S S S S S S
S327889 2016 F 22 LTV XDR R R R R R R S R R R S R S S 3
S320857 2016 M 43 LTV MDR R R R R R S S S S S S S S S
S316569 2016 M 54 North MDR R R R S S R R S S S S R S S
S326782 2016 M 62 North MDR R R R S S S S R S S S S S S 3
S340248 2016 M 20 LTV MDR R R R S R S S R S S S S S S 2
TB31393 2016 F 40 LTV MDR R R R S S S S S S S S S S S
S332846 2016 M 70 Centre MDR R R R S R S S S S S S S S S
S347401 2016 F 20 LTV MDR R R R R S S S R S S S S S S
ACC 2016 F 40 LTV MDR R R R S R S S R S S S S S S 2
S333605 2016 M 62 North MDR R R R S S S S R S S S S S S 3
S348387 2016 M UNK Centre MDR S R R S S S S S S S S S S S
S352139 2017 F 22 Centre MDR R R R R R S S S S S S S S S 6
S375001 2017 F 22 Centre MDR S R R R S S S R S S S S S S 5
S374686 2017 F 34 LTV MDR S R R R R S S R S S S S S S
S381277 2017 M 30 North MDR R R R R S S S S S S S S S S
TB33470 2017 M 52 LTV MDR S R R R R S S R S S S S S S 1
S389865 2017 F 59 North MDR R R R R R S S S S S S S S S
S387683 2017 M 56 LTV XDR R R R R R R S R R R S R S S 3
S399045 2017 F 41 North MDR R R R S S S S R R R S S S S
S396397 2017 M 51 LTV XDR R R R R R R R R S S S R S S 1
S399986 2017 M 58 LTV MDR R R R R S S S R R R S S S S 3
TB34192 2017 M 62 LTV MDR R R R S S S S R S S S S S S 2
2017 Only LPA M 54 North MDR NA R R NA NA NA NA NA NA NA NA NA NA NA
MDR: multidrug-resistant; XDR: extensively drug-resistant; TB: tuberculosis; STR: streptomycin; INH: isoniazid; RMP: rifampicin; EMB: ethambutol; PZA: pyrazinamide; AMI: amikacin;
CAP: capreomycin; ETI: ethionamide; MOX: moxifloxacin; OFL: ofloxacin; LIN: linezolid; KAN: kanamycin; CIC: cycloserine; PAS: para-aminosalicylic acid; M: male; F: female; LTV:
Lisbon and Tagus Valley; R: resistant; S: sensitive; NA: not available; LPA: line-probe assay; UNK: unknown.
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North region and the remaining clusters were mainly from LTV strains. Regarding the MDR-TB strains
isolated in 2015, three clusters were found, with a clustering rate of 55.0%, ranging from two to five
strains. All the clustered strains were from the LTV region with the exception of one strain that belonged
to a patient from the North region. In 2016, only two clusters were found with two and five strains, with a
clustering rate of 38.9%. The minor cluster was from a mother/child and the larger included strains from
the LTV and the North regions. Finally, in 2017, two clusters were identified with two strains each, all
from the LTV region, corresponding to a clustering rate of 36.4%.
When linking the epidemiological and the molecular data, we did not find a good agreement. After
adjustment for confirmed epidemiological links, the overall cluster rate (2014–2017) decreased from 63.4%
to 14.9%.
This study has a limitation related to the possible heterogeneity of the epidemiological enquiries. However,
it has the strength of collecting all MDR-TB samples in the country for 4 years to be analysed in the NRL.
We observed, in the studied period, a decreasing tendency both in the number of MDR-TB cases and the
clustering rates, despite a poor agreement between laboratory and epidemiological data. The centralisation
of the MDR-TB cases in reference centres seems to be effective, although there is a need for a better
molecular tool, with higher discriminatory power, and better inclusion of epidemiological data when
discussing these clusters.
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